Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia

Mostrar otras versiones (1)

BACKGROUND: Until now, the coronavirus disease 2019 (COVID-19) pandemic has affected more than 2.5 million individuals worldwide, with approximately 170,000 deaths. Currently, no treatments with robust evidence of clinical benefit exist, and utilization of experimental agents have been recommended b...

Descripción completa

Detalles Bibliográficos
Autores principales: Suna, Kavurgacı, Melahat, Uzel Şener, Murat, Yıldız, Figen, Öztürk Ergür, Ayperi, Öztürk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109827/
https://www.ncbi.nlm.nih.gov/pubmed/35601360
http://dx.doi.org/10.1016/j.medcle.2021.04.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109827/
https://www.ncbi.nlm.nih.gov/pubmed/35601360
http://dx.doi.org/10.1016/j.medcle.2021.04.027

Ejemplares similares